CAR-DC Targeting FAP therapy (Second Affiliated Hospital School Of Zhejiang University School Of Medicine)

N/A

Report date: 2026/04/15 20:02:38

Base Information

Drug NameCAR-DC Targeting FAP therapy (Second Affiliated Hospital School Of Zhejiang University School Of Medicine)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Chimeric antigen receptor dendritic cell therapy
Mechanisms of ActionDendritic cells modulatorsFibroblast activation protein alpha modulators
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsST Elevation Myocardial InfarctionShock, CardiogenicHeart Failure +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSecond Affiliated Hospital School Of Zhejiang University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesSecond Affiliated Hospital School Of Zhejiang University School Of Medicine
Inactive CompaniesN/A
Active IndicationsST Elevation Myocardial InfarctionShock, CardiogenicHeart Failure +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A